We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+8.22%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+468.9%
AUM
$920B
AUM Growth
+$99.4B
Cap. Flow
+$40.5B
Cap. Flow %
4.41%
Top 10 Hldgs %
19.57%
Holding
7,602
New
674
Increased
3,069
Reduced
2,328
Closed
737

Sector Composition

Rank Sector Weight
1 Technology 19.48%
2 Healthcare 10.48%
3 Financials 8.96%
4 Consumer Discretionary 8.42%
5 Industrials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXD icon
6526
ProShares UltraShort Health Care
RXD
$3.09M
$25 ﹤0.01%
1
XTOC icon
6527
Innovator US Equity Accelerated Plus ETF October
XTOC
$25.2M
$24 ﹤0.01%
1
FFAI
6528
Faraday Future Intelligent Electric
FFAI
$11.8M
0
ARAV
6529
DELISTED
Aravive, Inc. Common Stock
ARAV
$24 ﹤0.01%
19
BRID icon
6530
Bridgford Foods
BRID
$58M
$23 ﹤0.01%
2
TOI icon
6531
The Oncology Institute
TOI
$477M
$23 ﹤0.01%
42
-27,497
-100% -$14.5K
VANI icon
6532
Vivani Medical
VANI
$109M
$23 ﹤0.01%
19
BCEL
6533
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$23 ﹤0.01%
23
GOVXW
6534
DELISTED
GeoVax Labs Warrants
GOVXW
0
ATHX
6535
DELISTED
Athersys, Inc. Common Stock
ATHX
$22 ﹤0.01%
25
BCLI
6536
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$21 ﹤0.01%
1
-198
-99% -$8.21K
CNTG
6537
DELISTED
Centogene N.V. Common Shares
CNTG
$20 ﹤0.01%
13
-858
-99% -$726
OIG
6538
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$19 ﹤0.01%
+9
New +$23
CISO
6539
CISO Global
CISO
$11.5M
$18 ﹤0.01%
7
-3,418
-100% -$11.4K
FBRX icon
6540
Forte Biosciences
FBRX
$1.57B
$18 ﹤0.01%
1
FCTR icon
6541
First Trust Lunt US Factor Rotation ETF
FCTR
$51.7M
$18 ﹤0.01%
1
-1,535
-100% -$39.5K
GYRE icon
6542
Gyre Therapeutics
GYRE
$629M
$18 ﹤0.01%
3
HALL
6543
DELISTED
Hallmark Financial Services, Inc.
HALL
$17 ﹤0.01%
3
CNRG icon
6544
State Street SPDR S&P Kensho Clean Power ETF
CNRG
$187M
-2,280
Closed -$188K
VOC icon
6545
VOC Energy
VOC
$56.4M
$16 ﹤0.01%
+2
New +$16
ACGN
6546
DELISTED
Aceragen Inc
ACGN
$16 ﹤0.01%
10
AGRX
6547
DELISTED
Agile Therapeutics
AGRX
$15 ﹤0.01%
5
-1
-17% -$5
AXDX
6548
DELISTED
Accelerate Diagnostics
AXDX
$14 ﹤0.01%
2
LIDR icon
6549
AEye
LIDR
$47.2M
$14 ﹤0.01%
3
-2,608
-100% -$16.2K
WTER
6550
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$14 ﹤0.01%
+9
New +$14

Similar funds

JP Morgan Chase's Q2 2023 Portfolio in Review

As of Q2 2023, JP Morgan Chase held 7,602 positions worth $920B, up 12% from $821B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

JP Morgan Chase deployed $40.5B of net new capital in Q2 2023, opening 674 new positions and adding to 3,069 existing holdings. Its largest new stake was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $3.22B trimmed.

  • JP Morgan Chase's largest Q2 2023 buy was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
  • JP Morgan Chase added most to Microsoft in Q2 2023, an estimated $5.77B increase.
  • JP Morgan Chase's biggest Q2 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $3.22B.
  • JP Morgan Chase fully exited DCP Midstream, LP in Q2 2023, selling an estimated $328M.
  • JP Morgan Chase's ten largest holdings make up 20% of its $920B portfolio in Q2 2023.
  • JP Morgan Chase opened 674 new positions and closed 737 in Q2 2023.
  • JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $920B.

Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.